Hybrid Nanotechnologies for Detection and Synergistic Therapies for Breast Cancer
Abstract
This is a joint project by two Innovator Awardees and a Scholar to develop a novel nanotechnology platform for the diagnosis and treatment of breast cancer. The prevalence of breast cancer and the large number of deaths from this disease underscore the need for a paradigm shift in the strategies towards developing a cure for breast cancer. Nanotechnology has the potential of causing such a paradigm shift. Current work focuses on the development of novel peptide probes and probe strategies for the targeting of breast cancers, including very early pre-malignant lesions. Another focus is development of drug conjugates, nanomedicines and diagnostic nanosystems for therapeutic and theranostic targeting of breast cancers.
Document Details
- Document Type
- Technical Report
- Publication Date
- Oct 01, 2012
- Accession Number
- ADA569508
Entities
People
- Erkki Ruoslahti